[Purpose]This study provides empirical analysis on the cost-saving effects achieved by companies that adjusted executive compensation during the COVID-19 period. [Methodology]This study analyzes the impact of executive compensation adjustments on the capital market’s response and examines whether these adjustments can reduce capital procurement costs in corporate financial activities. [Findings]During the COVID-19 pandemic, executive compensation increased. Companies that reduced executive compensation showed a negative relationship with cumulative abnormal returns. However, there was a statistically significant negative relationship between reduced executive compensation and the cost of equity. This suggests that reducing executive compensation sends a positive signal to the capital market, indicating shareholder-friendly cost-saving efforts. Even during expected poor performance periods, reducing executive compensation positively impacts capital procurement. [Implications]This study suggests that external environmental factors significantly influence compensation structures. It highlights the importance of designing executive compensation for cost reduction, especially in the economic recession of the post-COVID era.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: